Capucine Arrivé

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Disease Activity

Rheumatoid Arthritis Patients

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Capucine Arrivé, Caroline Bazzoli, Thomas Jouve, Johan Noble, Lionel Rostaing, Françoise Stanke-Labesque, Zoubir Djerada
A Population Pharmacokinetic Model of Tocilizumab in Kidney Transplant Patients Treated for Chronic Active Antibody-Mediated Rejection: Comparison of Plasma Exposure Between Intravenous and Subcutaneous Administration Schemes. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)
Capucine Arrivé, Caroline Bazzoli, Thomas Jouve, Johan Noble, Lionel Rostaing, Françoise Stanke-Labesque, Zoubir Djerada
A Population Pharmacokinetic Model of Tocilizumab in Kidney Transplant Patients Treated for Chronic Active Antibody-Mediated Rejection: Comparison of Plasma Exposure Between Intravenous and Subcutaneous Administration Schemes. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (5) (2024)
Capucine Arrivé, Caroline Bazzoli, Thomas Jouve, Johan Noble, Lionel Rostaing, Françoise Stanke-Labesque, Zoubir Djerada
A Population Pharmacokinetic Model of Tocilizumab in Kidney Transplant Patients Treated for Chronic Active Antibody-Mediated Rejection: Comparison of Plasma Exposure Between Intravenous and Subcutaneous Administration Schemes. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (5) (2024)